PULMONIC, TRICUSPID & MITRAL INNOVATIONS

Tuesday, March 11, 2025

11:00 AM – 12:35 PM ET

Moderator(s)

Raoul I. Bonan, MD, FSCAI

Associate Professor of Medicine
Univerty of Montreal
Montreal, Quebec, Canada

Disclosure(s): Open Stent Solution: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)
Yair Feld, MD, PhD

Director -Interventional cardiology
Tzafon Medical Center (Poriya), Israel

Disclosure(s): No financial relationships to disclose
Steven L. Goldberg, MD, FSCAI, FACC

Interventional Cardiologist
SL Goldberg MD A Medical Corporation
Monterey, California, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing); Boston Scientific, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Celonova, Contego, Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Raoul I. Bonan, MD, FSCAI: Open Stent Solution: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

Yair Feld, MD, PhD: No financial relationships to disclose

Steven L. Goldberg, MD, FSCAI, FACC: Abbott Labs: Consultant (Ongoing); Boston Scientific, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Celonova, Contego, Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech: Consulting Fees (e.g., advisory boards) (Ongoing)